Academic Detailing now Available for this tool! Sign up Now
Type 2 Diabetes
According to Diabetes Canada, one in three Canadians has diabetes or prediabetes. This series of tools is designed to support family physicians and primary care nurse practitioners as they care for their patients living with type 2 diabetes.
Please note, the following resource was developed in the context of the COVID-19 pandemic, when necessity required deviation from existing evidence-based guidelines as in-person visits were significantly limited. Certain frameworks and guidance within the resource are applicable only to the "crisis care" needs during the COVID-19 pandemic and should be reviewed with this consideration in mind. Established Clinical Practice Guidelines are the authoritative source for evidence-based care.
For the most up-to-date information on this topic, Ontario family physicians can have a free, personalized academic detailing visit. Sign up today!
Stay connected or get support
About the tool
These tools are designed to support family physicians and primary care nurse practitioners individualize:
- A1c targets for their patients; relaxing or intensifying, when suitable.
- Adjustments in routine diabetes care during the COVID-19 pandemic.
- Choice of pharmacologic glycemic management approach according to proven benefit and harm as well as patient factors and preferences.
- Management of hypoglycemia and complex insulin care events.
The series of type 2 diabetes tools were developed using the Centre for Effective Practice’s (CEP’s) integrated knowledge translation approach. This approach ensures that providers are engaged throughout the development processes through the application of user-centred design methodology.
These tools are some of several clinical tools developed as part of the Knowledge Translation in Primary Care Initiative. It was developed in collaboration with the Nurse Practitioners’ Association of Ontario (NPAO). Funded by the Ministry of Health and Long-Term Care, the initiative supports primary care providers with the development of a series of clinical tools and health information resources. Learn more about the Knowledge Translation in Primary Care Initiative (KTinPC).
Please note: Dr. Risa Bordman is clinical lead for the Type 2 Diabetes: Non-Insulin Pharmacotherapy and Type 2 Diabetes: Insulin Therapy tools. A separate group of providers were involved in the development of the Managing Type 2 Diabetes During COVID-19 Tool - learn more about this group here.
Dr. Risa Bordman is a family physician and palliative care clinician in Toronto. She has extensive experience in research and education and is an Associate Professor at The University of Toronto and McMaster University. She is the Residency Program Director at the Foundation for Medical Practice Education, Faculty Development lead for the Office of Education Scholarship at the University of Toronto and Co-chair Palliative Care Education Committee, Division of Palliative Care, University of Toronto.
Dr. Bordman provided clinical leadership for the non-insulin pharmacotherapy and insulin therapy for type 2 diabetes topics.
End user and expert feedback
End users and a group of clinical experts were engaged to provide feedback throughout the development of these tools.
Conflict of Interest
The clinical lead received compensation for her role.
Topic expert group members received an honorarium for their participation.
Usability participants received a token of appreciation (e.g., gift certificate).
Thank you to everyone who supported the development of this tool!